Bipolar and OAP Flashcards
Bipolar disorder: Hypomanic episode
Ssymptoms lasting for at least several days
* persistent elevated mood
* persistent irritability
* increase activity/energy
* increase talkativeness
* rapid/racing thoughts
* increase self-esteem
* decrease need for sleep
* distractibility
* impulsive/reckless behaviour
* Significant change from usual mood, energy and behaviour but no impairment in functioning
Bipolar type 2 disorder
- Lifetime prevalence 0.4% in adults
- Onset: late adolescent to mid-20s. Often with one or more depressive episodes which might be unrecognised before symptoms of hypomania emerged.
- 15% may subsequently develop episodes of mania – change diagnosis to Bipolar I= (always review diagnosis at each patient contact)
- Significant FH of Bipolar Disorders
- Increase suicide risk esp during depressive episodes
- Recurrent panic attacks may indicate greater severity of illness, poorer response to treatment & higher risk of suicide
- Increase risk of developing medical condition eg cardiovascular diseases, metabolic syndrome due to the effect of medications used to treat Bipolar II Disorders.
- Higher rates of Anxiety/Fear Related Disorders and Disorders of Substance Use.
Risks in bipolar affective disorder
- Overspending, debts
- Disinhibition (incl. promiscuity, pregnancy)
- Exploitation – financial, relationship,
- Driving
- Family/Children
- Violence – self & others
- Self-neglect – personal care, physical health
- Suicide: 15x higher then the general population
- Alcohol and Recreational substances
What is mania/hypomania
- both terms relate to abnormally elevated mood or irritability
- with mania, there is severe functional impairment or psychotic symptoms for 7 days or more
- hypomania describes decreased or increased function for 4 days or more
- from an exam point of view the key differentiation is psychotic symptoms (e.g.delusions of grandeur or auditory hallucinations) which suggest mania
Management of bipolar disorder
- psychological interventions specifically designed for bipolar disorder may be helpful
- lithium remains the mood stabilizer of choice. An alternative is valproate
- management of mania/hypomania= consider stopping antidepressant if the patient takes one; antipsychotic therapy e.g. olanzapine or haloperidol
- management of depression= talking therapies (see above); fluoxetine is the antidepressant of choice
- address co-morbidities= there is a 2-3 times increased risk of diabetes, cardiovascular disease and COPD
Bipolar disorder: primary care referral
- if symptoms suggest hypomania then NICE recommend routine referral to the community mental health team (CMHT)
- if there are features of mania or severe depression then an urgent referral to the CMHT should be made
Bipolar disorder: diagnostic challenges 1
- Clinically difficult to diagnose Bipolar Disorders in a single assessment.
- Diagnostic criteria for depressive episodes: identical in bipolar disorder and depressive disorder. Bipolar disorder is often misdiagnosed as depressive disorder
- Bipolar II is difficult to distinguish from depressive disorder because of the frequent depressive episodes and absence of full-blown mania
- Depressive symptoms are common in bipolar disorders and their prevalence is higher than that of hypomanic or manic symptoms
Bipolar disorder: diagnostic challenges 2
- Mixed mood episodes are more common that previously thought in bipolar disorder. These episodes might obscure detection of mania and hypomania due to patients’ reporting bias (some patients prefer to be in hypomanic state as they can get more things done)
- Subthreshold symptoms of hypomania are common in depression
- A subset of patients with treatment-resistant depressive disorder might have misdiagnosed bipolar disorder
Examples of rating scales in mood disorders: self reported
- Mood Disorder Questionnaire (MDQ) – brief screen – 12 or 3 item
- Young Mania Rating Scale (YMRS)
- Patient Health Questionnaire (PHQ)
- Beck Depression Inventory – BDI, most commonly used in clinical diagnosis
- Quick Inventory Depressive Symptomatology-Self Report (QIDS-SR)
Examples of rating scales in mood disorders: interview with physician
- Hamilton Depression Rating Scale (HAMD)
- Montgomery and Asberg Depression Rating Scale (MADRS)
- Quick Inventory Depressive Symptomatology – Clinician (QIDS-C)
Biological management of bipolar disorder: first episode (manic or hypomanic)
- If the individual is on antidepressant (as treatment for depression), consider stopping antidepressant.
- Start antipsychotics – choice of risperidone, olanzapine, haloperidol, quetiapine. Titrate dose carefully.
- Monitor for side-effects – acute dystonia, akathisia, EPSE
- If first antipsychotic is poorly tolerated or if no response, choose another antipsychotic
- Benzodiazepine – short term use only & if necessary Review daily. Long term use of benzodiazepine cause dependence & potential withdrawal symptoms
- Other options: choice of Lithium, Valproate, Aripiprazole. Sodium valproate cant be given to women of child bearing age due to teratogenicity
Biological management of bipolar disorder: acute depressive episode (moderate to severe bipolar depression)
- If not on treatment for bipolar disorder:
- Fluoxetine plus Olanzapine or Quetiapine on its own
- Can offer either Olanzapine or Lamotrigine on its own
- If no response to combination of fluoxetine plus Olanzapine or Quetiapine, offer Lamotrigine on its own
Treatment for acute depressive episode (moderate to severe bipolar disorder): if already on lithium
- Check Li level & adjust dosage appropriately. If Lithium is at max, based on patient’s preference & previous experience, offer combination of Lithium with:
- Fluoxetine + Olanzapine or Quetiapine
- Can add Olanzapine (without Fluoxetine)
- Stop if no response to combination of Fluoxetine + Olanzapine or adding Quetiapine
- Consider combination of Lamotrigine to Lithium
Treatment for acute depressive episode (moderate to severe bipolar disorder): if already on valproate
- Consider increasing the dose within therapeutic range to maximum tolerated dose. If already at max, based on patient’s preferences & experience, offer combination of Valproate with
- Fluoxetine + Olanzapine or Quetiapine
- Can add Olanzapine (without Fluoxetine)
- Stop if no response to Fluoxetine + Olanzapine or adding Quetiapine
- Consider combining Lamotrigine to Valproate
Long term management of bipolar disorder: biological
- Shared decision making. Discuss what pharmacological intervention that worked in the past, potential benefits and risks of medications in the shorter & longer term, medication concordance, side-effects & drug interactions inc over the counter preparation. Risks of relapse without meds.
- First Line: Lithium, If Li ineffective, offer Valproate (Not of women of child bearing age)
- Alternative consider Olanzapine, Quetiapine
Long term management of bipolar disorder: Psychological
- Educate patients and carers (with patients’ consent) about nature & severity of illness.
- The aim is to empower patients to manage their illness – self-monitoring, recognition of early warning signs eg decrease need for sleep may trigger a manic relapse.
- Discuss about future management according to patients’ preferences inc advance directive
- Offer CBT/Interpersonal Therapy/Family Intervention according to patients’ needs & preferences.
Long term management of bipolar disorder: social
- The aim is to return to premorbid functioning level in terms of education & employment.
- Lifestyle advice on smoking/alcohol/recreational substances/exercise/diet
- Support group: Bipolar UK
Bipolar disorder issues in treatment: Lithium
- Narrow therapeutic index – initially measure weekly till levels stable, monitor levels 3 monthly thereafter.
- Renal and thyroid dysfunction – renal function + TFTs 6 monthly
- Sudden discontinuation – 50% risk of mania
- Pregnancy= Avoid, if possible, particularly in the first trimester (risk of teratogenicity, including cardiac abnormalities - Ebstein anomaly. Dose requirements increased during the second and third trimesters (but on delivery return abruptly to normal). Close monitoring of serum-lithium concentration advised in pregnancy (risk of toxicity in neonate).
Bipolar disorder issues in treatment: Valproate and Lamotrigine
- Valproate: not for women of child bearing age. Reduced IQ (10-15 points), teratogenicity (neural tube), polycystic ovary. Levels if ineffective, poor adherence or toxicity
- Lamotrigine: risk of Stevens-Johnson syndrome, slow dose titration
Combination of antidepressant and antipsychotic are indicated for the treatment of depressive disorder with psychotic symptoms. For example, Sertraline and Ariprazole
Neurostimulation
- ECT
- Transcranial magnetic stimulation (TMS)
- Others: Vagus nerve stimulation, Transcranial direct current stimulation (tDCS), Deep brain stimulation